Cantor Fitzgerald Reiterates Overweight on Affimed, Maintains $7 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Li Watsek has reiterated an Overweight rating on Affimed (NASDAQ:AFMD) and maintained a $7 price target.
September 25, 2023 | 2:09 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Affimed's stock rating has been reiterated as Overweight by Cantor Fitzgerald, with a maintained price target of $7.
The reiteration of an Overweight rating by a reputable analyst like Cantor Fitzgerald is a positive signal for Affimed. The maintained price target of $7 also indicates the analyst's confidence in the company's performance. This could potentially lead to an increase in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100